Rik Ossenkoppele
Impact in
- Psychiatry and Mental health top 0.05%
- Dementia and Cognitive Impairment Research
- Physiology top 0.1%
- Alzheimer's disease research and treatments
Papers in
-
- Dementia and Cognitive Impairment Research 239
- Physiology 128
- Alzheimer's disease research and treatments 126
- Co-authors
- Oskar Hansson (94 shared papers)Philip Scheltens (103 shared papers)Wiesje M. van der Flier (99 shared papers)Rik van der Kant (3 shared papers)Bart N.M. van Berckel (73 shared papers)Ruben A Smith (50 shared papers)Gil Rabinovici (43 shared papers)Olof T. Strandberg (48 shared papers)
- Journals
- Alzheimer s & Dementia (110 papers)Alzheimer s Research & Therapy (26 papers)Neurology (23 papers)Brain (22 papers)European Journal of Nuclear Medicine and Molecular Imaging (19 papers)
- Partner nations
- NetherlandsSwedenUnited States
In The Last Decade
Rik Ossenkoppele
344 papers receiving 20.9k citations
Rik Ossenkoppele's Hit Papers
Peers
Comparison fields: 5 of 165
- Psychiatry and Mental health 9.7k
- Physiology 8.3k
- Neurology 2.1k
- Cognitive Neuroscience 4.1k
- Biological Psychiatry 419
Countries citing papers authored by Rik Ossenkoppele
This map shows the geographic impact of Rik Ossenkoppele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rik Ossenkoppele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rik Ossenkoppele more than expected).
Fields of papers citing papers by Rik Ossenkoppele
This network shows the impact of papers produced by Rik Ossenkoppele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rik Ossenkoppele. The network helps show where Rik Ossenkoppele may publish in the future.
Co-authors
The 25 scholars most cited alongside Rik Ossenkoppele, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 367 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia Hit paper breakdown → | 2015 | 1300 |
| 2 | Brain charts for the human lifespan Hit paper breakdown → | 2022 | 1043 |
| 3 | PET Imaging of Tau Deposition in the Aging Human Brain Hit paper breakdown → | 2016 | 958 |
| 4 | Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease Hit paper breakdown → | 2016 | 928 |
| 5 | Prevalence of Amyloid PET Positivity in Dementia Syndromes Hit paper breakdown → | 2015 | 542 |
| 6 | Four distinct trajectories of tau deposition identified in Alzheimer’s disease Hit paper breakdown → | 2021 | 521 |
| 7 | The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials Hit paper breakdown → | 2015 | 475 |
| 8 | Amyloid-β-independent regulators of tau pathology in Alzheimer disease Hit paper breakdown → | 2019 | 459 |
| 9 | The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features Hit paper breakdown → | 2015 | 419 |
| 10 | Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease Hit paper breakdown → | 2020 | 378 |
| 11 | Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias Hit paper breakdown → | 2020 | 377 |
| 12 | Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials Hit paper breakdown → | 2022 | 375 |
| 13 | Discriminative Accuracy of [ 18 F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders Hit paper breakdown → | 2018 | 361 |
| 14 | The probabilistic model of Alzheimer disease: the amyloid hypothesis revised Hit paper breakdown → | 2021 | 352 |
| 15 | Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline Hit paper breakdown → | 2022 | 328 |
| 16 | Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid tests Hit paper breakdown → | 2024 | 300 |
| 17 | Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease Hit paper breakdown → | 2020 | 277 |
| 18 | Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease Hit paper breakdown → | 2020 | 258 |
| 19 | 2017 | 256 | |
| 20 | 2019 | 242 |
About Rik Ossenkoppele
Rik Ossenkoppele is a scholar working on Psychiatry and Mental health, Physiology, Cognitive Neuroscience, Radiology, Nuclear Medicine and Imaging and Neurology, having authored 367 papers that have together received 21.3k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (239 papers), Alzheimer's disease research and treatments (126 papers), Functional Brain Connectivity Studies (59 papers), Medical Imaging Techniques and Applications (37 papers), Advanced Neuroimaging Techniques and Applications (24 papers), Neurological Disease Mechanisms and Treatments (17 papers), Advanced MRI Techniques and Applications (13 papers) and Parkinson's Disease Mechanisms and Treatments (10 papers). The work is most often cited by research in Psychiatry and Mental health (9.7k citations), Physiology (8.3k citations), Neurology (2.1k citations), Cognitive Neuroscience (4.1k citations) and Biological Psychiatry (419 citations). Rik Ossenkoppele has collaborated with scholars based in Netherlands, Sweden and United States. Frequent co-authors include Oskar Hansson, Philip Scheltens, Wiesje M. van der Flier, Rik van der Kant, Bart N.M. van Berckel, Ruben A Smith, Gil Rabinovici, Olof T. Strandberg, Niklas Mattsson-Carlgren and Frederik Barkhof. Their work appears in journals such as Alzheimer s & Dementia, Alzheimer s Research & Therapy, Neurology, Brain and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.